U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911476) titled 'From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19' on April 01.
Brief Summary: Rationale: The diagnosis and pathogenesis of long COVID remains unknown. We have previously shown that [68Ga]FAPI Positron Emission Tomography-Computed Tomography (PET/CT) imaging shows potential for diagnosis and molecular understanding of this syndrome. We have previously shown that fibroblast activation protein (FAP) can be imaged in the lung, muscle and nasopharynx of long COVID patients (with dyspnea and fatigue). However, these preliminary data are derived from a selective group of patients with long ...